Hodgkinlymfóma

Hodgkin lymphoma is a type of cancer that affects the lymphatic system, which is part of the body's immune system. It is named after Sir Thomas Hodgkin, an English physician who first described the disease in 1832. The disease is characterized by the presence of Reed-Sternberg cells, which are large, abnormal cells that can be seen under a microscope.

Hodgkin lymphoma is typically diagnosed in young adults, with a peak incidence between the ages of 15 and 35. It is more common in men than in women. The disease can be classified into two main types: nodular sclerosis and mixed cellularity. Nodular sclerosis is the most common type and is characterized by the presence of a dense, fibrous tissue called sclerosis. Mixed cellularity is less common and is characterized by a mixture of different types of cells.

The treatment of Hodgkin lymphoma typically involves a combination of chemotherapy, radiation therapy, and sometimes surgery. The goal of treatment is to shrink the tumor and eliminate any remaining cancer cells. In some cases, a stem cell transplant may be recommended to help the body's immune system recover.

Hodgkin lymphoma is generally considered a curable disease, with a five-year survival rate of over 90% for patients who receive appropriate treatment. However, the disease can recur in some patients, and long-term follow-up care is often necessary to monitor for any signs of recurrence.